title: Postmortem in situ micro-CT evaluation of coronary stent fracture.
abstract: Coronary stent fracture has been postulated as an important mechanism for in-stent restenosis and late-stent thrombosis. We have developed a nondestructive microcomputed tomography (micro-CT) technique to image en bloc stented arterial segments.
  
  
  METHODS
  A 43-year-old man died of sepsis 5 months following placement of a paclitaxel-eluting stent (PES) in the left circumflex coronary artery to treat in-stent restenosis of a sirolimus-eluting stent (SES). Micro-CT three-dimensional images of the overlapping stents were notable for numerous connecting element fractures along the length of the SES. No fractures were observed in the PES. The greatest area of luminal narrowing is related to the region of most extensive stent fracture. Micro-CT of en bloc specimens provides high resolution (16 μm), three-dimensional images allowing for visualization of the stented arterial segment in a nondestructive manner.
authors.affiliation: Cardiology Section, Dartmouth Medical School/Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756-0001, USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Foerst
authors.forename: Timothy
authors.initials: T
authors.lastname: Ball
authors.forename: Aaron V
authors.initials: AV
authors.lastname: Kaplan
mesh_terms: D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D001344:Autopsy; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D054855:Drug-Eluting Stents; D017809:Fatal Outcome; D006801:Humans; D021621:Imaging, Three-Dimensional; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D011474:Prosthesis Design; D011475:Prosthesis Failure; D011857:Radiographic Image Interpretation, Computer-Assisted; D016896:Treatment Outcome; D055114:X-Ray Microtomography
chemical_list: D002317:Cardiovascular Agents; D017239:Paclitaxel